Individualizing the Treatment of Type 2 Diabetes With a Focus on Cardiovascular Outcomes

1.25 CME
0 MINS
$0 FEE
SAVE

Provider Statement: This continuing medical education activity is provided by The American Association of Clinical Endocrinologists  

Support Statement: This activity is supported by an educational grant from the Merck/Pfizer Alliance. 

Program Management: Vindico Medical Education

Learner Bill of Rights: Please click here

Target Audience: The intended audience for this activity is endocrinologists and other health care professionals involved in the treatment of patients with type 2 diabetes mellitus (T2DM).

Learning Objectives: Upon successful completion of this activity, participants should be better able to:

  • Review the impact of antidiabetic medications in patients with multiple comorbidities such as hypertension, reduced renal function, obesity, and cardiovascular disease.
  • Incorporate individualized treatment strategies for patients with type 2 diabetes and cardiovascular risk factors based on the latest clinical evidence.
  • Apply clinical evidence on medications’ efficacy and safety when selecting monotherapy or combination therapy in patients with type 2 diabetes and cardiovascular risk factors.

CME Accreditation Committee and Disclosures: Please click here

Activity Chair:
Yehuda Handelsman, MD, FACP, FNLA, MACE
Medical Director and Principal Investigator
Metabolic Institute of America
Past President, ACE and AACE
Tarzana, CA

Faculty:
Vivian A. Fonseca, MD, FRCP, FACE
Professor of Medicine and Pharmacology
Assistant Dean for Clinical Research
Tullis–Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
New Orleans, LA

George Grunberger, MD, FACP, FACE
Chairman, Grunberger Diabetes Institute
Clinical Professor, Internal Medicine and
Molecular Medicine and Genetics
Wayne State University School of Medicine
Professor, Internal Medicine
Oakland University William Beaumont School of Medicine
Visiting Professor, Internal Medicine
First Faculty of Medicine, Charles University
Prague, Czech Republic
Past President, AACE
President Elect, ACE
Detroit, MI

Carol H. Wysham, MD, FACP, FACE
Clinical Professor of Medicine
University of Washington School of Medicine
Section Head, Rockwood Center for
Diabetes and Endocrinology
Spokane, WA

Accreditation:
The American Association of Clinical Endocrinologists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:
The American Association of Clinical Endocrinologists designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, October 1, 2018 through September 30, 2019.

How to Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, watch the presentations, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, The American Association of Clinical Endocrinologists will issue an AMA PRA Category 1 Credit(s)™ Certificate.

Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, faculty, reviewers, and staff involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Activity Chair and Faculty members report the following relationship(s):
Vivian A. Fonseca, MD, FRCP, FACE
Contracted Research (Paid to Institution): Bayer, Boehringer Ingelheim

George Grunberger, MD, FACP, FACE
Speakers Bureau: AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Novo Nordisk, Sanofi
Contracted Research:
Eli Lilly, Medtronic, Novo Nordisk

Yehuda Handelsman, MD, FACP, FNLA, MACE
Consulting Fee: Amarin, Amgen, Amylin, Boehringer Ingelheim, Gilead, GlaxoSmithKline, Halozyme, Janssen, Merck, Novo Nordisk, Sanofi, Vivus
Speakers Bureau:
Amarin, Amylin, Boehringer Ingelheim, GlaxoSmithKline, Janssen, Novo Nordisk, Vivus
Contracted Research:
Amgen, Boehringer Ingelheim, Gilead, GlaxoSmithKline, Intarcia, Lexicon, Merck, Novo Nordisk, Sanofi, Takeda

Carol H. Wysham, MD, FACP, FACE
Consulting Fee:
Abbott Medical Optics, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Novo Nordisk, Sanofi Aventis
Speakers Bureau:
AstraZeneca, Boehringer Ingelheim, Eli Lilly, Insulet, Janssen, Novo Nordisk, Sanofi Aventis

The American Association of Clinical Endocrinologists and Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.

Signed disclosures are on file at The American Association of Clinical Endocrinologists and Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2018 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of The American Association of Clinical Endocrinologists and Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of The American Association of Clinical Endocrinologists and Vindico Medical Education. Neither The American Association of Clinical Endocrinologists, Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

For questions regarding this CME activity, please contact: AACE CME Department - Phone: (904) 353-7878, Email: cme@aace.com.